港股异动 | 医药股涨幅居前再鼎医药(09688)涨近15% 和铂医药-B(02142)涨超10%

智通财经2025-04-14

智通财经APP获悉，医药股早盘涨幅居前，截至发稿，再鼎医药(09688)涨14.86%，报25.5港元；和铂医药-B(02142)涨10.07%，报7.87港元；荣昌生物(09995)涨8.22%，报30.95港元；君实生物(01877)涨8.1%，报15.22港元；来凯医药-B(02105)涨7.71%，报11.46港元。广发证券认为，当前资本市场的关注焦点正悄然从传统的地产和政策周期转向更具...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2527949291?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-04-14 09:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2527949291","market":"us","top_or_hot":-1,"title":"港股异动 | 医药股涨幅居前 再鼎医药(09688)涨近15% 和铂医药-B(02142)涨超10%","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，医药股早盘涨幅居前，截至发稿，再鼎医药(09688)涨14.86%，报25.5港元；和铂医药-B(02142)涨10.07%，报7.87港元；荣昌生物(09995)涨8.22%，报30.95港元；君实生物(01877)涨8.1%，报15.22港元；来凯医药-B(02105)涨7.71%，报11.46港元。广发证券认为，当前资本市场的关注焦点正悄然从传统的地产和政策周期转向更具...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1277939.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 医药股涨幅居前 再鼎医药(09688)涨近15% 和铂医药-B(02142)涨超10%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 医药股涨幅居前 再鼎医药(09688)涨近15% 和铂医药-B(02142)涨超10%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-04-14 09:57 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1277939.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，医药股早盘涨幅居前，截至发稿，再鼎医药(09688)涨14.86%，报25.5港元；和铂医药-B(02142)涨10.07%，报7.87港元；荣昌生物(09995)涨8.22%，报30.95港元；君实生物(01877)涨8.1%，报15.22港元；来凯医药-B(02105)涨7.71%，报11.46港元。广发证券认为，当前资本市场的关注焦点正悄然从传统的地产和政策周期转向更具...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1277939.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02105","symbol_name":"来凯医药-B","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1277939.html","article_id":"2527949291","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2527949291","pubTimestamp":1744595830,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，医药股早盘涨幅居前，截至发稿，再鼎医药涨14.86%，报25.5港元；和铂医药-B涨10.07%，报7.87港元；荣昌生物涨8.22%，报30.95港元；君实生物涨8.1%，报15.22港元；来凯医药-B涨7.71%，报11.46港元。此外，财报层面：头部港股创新药公司受益于License-out放量，营收和利润稳步增长。该行表示，年初以来在DeepSeek的激励下，港股市场交投情形改善显著，相比之下，港股医药板块的关注度并不算高，对医药的基本面修复，市场定价或尚不充分。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159938":"医药","02105":"来凯医药-B","BK1161":"生物科技","BK1588":"回港中概股","09995":"荣昌生物","LU1969619763.USD":"EASTSPRING INV CHINA A SHARES GROWTH \"A\" (USD) ACC","BK4531":"中概回港概念","BK1515":"抗疫概念","BK4526":"热门中概股","09939":"开拓药业-B","BK4585":"ETF&股票定投概念","BK1574":"生物医药B类股","BK4139":"生物科技","BK1583":"高瓴概念","LU2328871848.SGD":"Eastspring Investments - China A Shares Growth AS SGD","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","09688":"再鼎医药","BK4588":"碎股","BK4548":"巴美列捷福持仓","02142":"和铂医药-B","01877":"君实生物","ZLAB":"再鼎医药"},"translate_title":"Hong Kong stocks changed, pharmaceutical stocks were among the top gainers, Zai Lab (09688) rose nearly 15% and Platinum Pharmaceuticals-B (02142) rose more than 10%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159938":1,"02142":1,"09688":1,"01877":0.9,"09939":1,"09995":0.9,"02105":0.9,"ZLAB":1},"content_text":"智通财经APP获悉，医药股早盘涨幅居前，截至发稿，再鼎医药(09688)涨14.86%，报25.5港元；和铂医药-B(02142)涨10.07%，报7.87港元；荣昌生物(09995)涨8.22%，报30.95港元；君实生物(01877)涨8.1%，报15.22港元；来凯医药-B(02105)涨7.71%，报11.46港元。广发证券认为，当前资本市场的关注焦点正悄然从传统的地产和政策周期转向更具长期战略意义的中美科技博弈。该行建议重视港股创新药的配置价值，原因在于：核心逻辑一：中国创新药出海的全球竞争优势正在凸显；核心逻辑二：当前关税政策对创新药影响远小于其他成长性板块；核心逻辑三：政策及监管态度逐步转向对板块有利的情形。2023年下半年以来，政策层面出现了一系列积极信号，标志着行业监管思路的调整，包括但不限于集采规则优化、创新药支持政策加码、医疗反腐常态化与纠偏。此外，财报层面：头部港股创新药公司受益于License-out放量，营收和利润稳步增长。估值层面：年初以来科技股的放量大涨之后，医药板块相比于其他成长行业，估值处于相对安全的区间。该行表示，年初以来在DeepSeek的激励下，港股市场交投情形改善显著，相比之下，港股医药板块的关注度并不算高，对医药的基本面修复，市场定价或尚不充分。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2527949291","isCrawlerRequest":true}

港股异动 | 医药股涨幅居前 再鼎医药(09688)涨近15% 和铂医药-B(02142)涨超10%

精彩评论

港股异动 | 医药股涨幅居前再鼎医药(09688)涨近15% 和铂医药-B(02142)涨超10%